Bjornsson TD[au] - Search Results

Year	Number of Results
1977	3
1978	3
1979	7
1980	5
1981	5
1982	6
1983	8
1984	8
1985	4
1986	6
1987	3
1988	5
1989	6
1990	2
1991	3
1992	4
1993	5
1994	2
1995	5
1996	3
1997	3
1998	2
2000	1
2003	3
2007	1
2015	1
2016	1
2022	0

1

Dipyridamol kinetics.

Mahony C, Wolfram KM, Cocchetto DM, Bjornsson TD. Mahony C, et al. Among authors: bjornsson td. Clin Pharmacol Ther. 1982 Mar;31(3):330-8. doi: 10.1038/clpt.1982.42. Clin Pharmacol Ther. 1982. PMID: 7060316

2

Pharmacometrics and the transition to model-based development.

Grasela TH, Dement CW, Kolterman OG, Fineman MS, Grasela DM, Honig P, Antal EJ, Bjornsson TD, Loh E. Grasela TH, et al. Among authors: bjornsson td. Clin Pharmacol Ther. 2007 Aug;82(2):137-42. doi: 10.1038/sj.clpt.6100270. Clin Pharmacol Ther. 2007. PMID: 17632539 Review.

3

Use of serum creatinine concentrations to determine renal function.

Bjornsson TD. Bjornsson TD. Clin Pharmacokinet. 1979 May-Jun;4(3):200-22. doi: 10.2165/00003088-197904030-00003. Clin Pharmacokinet. 1979. PMID: 383355 Review.

4

A classification of drug action based on therapeutic effects.

Bjornsson TD. Bjornsson TD. J Clin Pharmacol. 1996 Aug;36(8):669-73. doi: 10.1002/j.1552-4604.1996.tb04234.x. J Clin Pharmacol. 1996. PMID: 8877669 Review.

5

Methods for vascular access and collection of body fluids from the laboratory rat.

Cocchetto DM, Bjornsson TD. Cocchetto DM, et al. Among authors: bjornsson td. J Pharm Sci. 1983 May;72(5):465-92. doi: 10.1002/jps.2600720503. J Pharm Sci. 1983. PMID: 6345750 Review. No abstract available.

6

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups. Bjornsson TD, et al. J Clin Pharmacol. 2003 May;43(5):443-69. J Clin Pharmacol. 2003. PMID: 12751267 Review.

7

A review and assessment of potential sources of ethnic differences in drug responsiveness.

Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, Stalker DJ, Wise SD, Dombey S, Loew C. Bjornsson TD, et al. J Clin Pharmacol. 2003 Sep;43(9):943-67. doi: 10.1177/0091270003256065. J Clin Pharmacol. 2003. PMID: 12971027 Review.

8

Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations.

Bjornsson TD. Bjornsson TD. Eur J Drug Metab Pharmacokinet. 1997 Jan-Mar;22(1):1-14. doi: 10.1007/BF03189779. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9179555 Review.

9

Lidocaine plasma protein binding.

Routledge PA, Barchowsky A, Bjornsson TD, Kitchell BB, Shand DG. Routledge PA, et al. Among authors: bjornsson td. Clin Pharmacol Ther. 1980 Mar;27(3):347-51. doi: 10.1038/clpt.1980.46. Clin Pharmacol Ther. 1980. PMID: 7357791

10

Clinical pharmacokinetics of dipyridamole.

Bjornsson TD, Mahony C. Bjornsson TD, et al. Thromb Res Suppl. 1983;4:93-104. doi: 10.1016/0049-3848(83)90364-x. Thromb Res Suppl. 1983. PMID: 6579711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results